OPKO HEALTH, INC. (OPK)


Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading OPKO HEALTH, INC. chart...

About the Company

OPKO Health is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

339

Exchange

Nasdaq

$2B

Total Revenue

339

Employees

$950M

Market Capitalization

-12.62

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $OPK News

OPKO Health, Inc. (OPK)

2d ago, source: Yahoo Finance

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced ...

Opko Health

7d ago, source: Forbes

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company. The company is engaged in discovering, developing, commercializing and expertise its novel and proprietary ...

OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp

17d ago, source: Zacks.com on MSN

OPKO Health, Inc. OPK recently entered into an agreement with Laboratory Corporation of America Holdings, Inc. LH or Labcorp.

Critical Insights From OPKO Health Analyst Ratings: What You Need To Know

17d ago, source:

Insights from analysts' 12-month price targets are revealed, presenting an average target of $2.75, a high estimate of $5.00, ...

Labcorp to pay Opko $237.5M for select Bioreference assets

16d ago, source: BioWorld

Laboratory Corporation of America Holdings Inc. agreed to purchase select assets of Bioreference Health from Opko Health Inc.

OPKO Health Stock (NASDAQ:OPK), Analyst Ratings, Price Targets, Predictions

18d ago, source: Benzinga.com

OPKO Health Inc has a consensus price target of $4.13, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Barrington Research, Piper Sandler ...

Opko Health Buy Rating Backed by Strategic Asset Sale and Promising Oral Drug Candidate

16d ago, source:

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Opko Health (OPK – Research Report) today and set a price target of $3.00. Yi ...

OPKO Health Inc OPK

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Critical Insights From OPKO Health Analyst Ratings: What You Need To Know

17d ago, source: Business Insider

Unveiling the Story Behind OPKO Health OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...